Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > Teva Introduces Generic Equivalent of Symbyax in U.S.

FDAnews Drug Daily Bulletin

June 25, 2012 | Vol. 9 No. 124

Teva Introduces Generic Equivalent of Symbyax in U.S.

Teva Pharmaceutical has launched Olanzapine and Fluoxetine Capsules USP 6mg/25mg, 12mg/25mg, 6mg/50mg and 12mg/50mg. The olanzapine and fluoxetine capsules are the company’s generic equivalent to Symbyax.
Pharmaceutical Business Review

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Full Issue FDA Advisers Recommend Merck Insomnia Drug; Downplay Need for Additional Trials Senate Preps Track-and-Trace, Compounding Reform Bills for Floor Vote Ranbaxy Compliance Reforms Reflect FDA Manufacturing Recommendations

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.